Human Immune Response to Ixodes Scapularis Tick Bites
NCT05036707 · Status: RECRUITING · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2026-05-06
Summary
Background:
Each year, the number of cases of tick-borne diseases increases. The deer tick (Ixodes scapularis) is the vector of at least 7 pathogens that cause human diseases, including Lyme disease. Researchers want to learn more to help them develop vaccines against ticks in the future.
Objective:
To learn how people s bodies, particularly the skin, respond to tick bites.
Eligibility:
Healthy adults aged 18 years and older who have no known history of a tick-borne disease or tick bite exposure.
Design:
Participants will be screened with a medical history, physical exam, and blood tests.
Participants will have 2 skin punch biopsies of healthy skin. For this, a sharp instrument will be used to remove a round plug of skin about the size of a pencil eraser. Participants will then have 10 clean laboratory-bred ticks placed at 2 different sites on their skin (20 ticks total). The ticks will be removed from the first site 1 day after placement and from the second site 2-4 days after placement. Participants will complete symptom diary cards. They will answer questions about itching at the tick feeding sites. They will give blood samples. Photos will be taken of the tick feeding sites. Skin punch biopsies will be collected at the sites of the tick bites.
Participants will repeat the tick feeding procedures 2 times, each 2-8 weeks apart. For the 2nd and 3rd procedures, 10 clean laboratory-bred ticks will be placed at 1 site. The ticks will be removed 2-3 days after tick placement. They will have telephone follow-up visits after each procedure.
After the final tick removal, participants will have follow-up visits in 4-6 weeks and again in 3 months. They will give blood samples and discuss how they are feeling.
Participation will last about 5-7 months.
Conditions
- Tick-borne Diseases
- Tick Resistance
- Lyme Disease
Interventions
- DEVICE
-
Xenodiagnosis Ticks
Larval ticks will be obtained from Dr. Sam Telford from a laboratory maintained tick colony at Tufts Veterinary School. These ticks are hatched from eggs laid by ticks that have fed only on specific pathogen free laboratory animals that were purchased from established vendors.
- PROCEDURE
-
skin biopsy
2-3 mm skin punch biopsies will be performed.
- PROCEDURE
-
blood draw
Peripheral blood draws will be performed.
Sponsors & Collaborators
-
National Institute of Allergy and Infectious Diseases (NIAID)
lead NIH
Principal Investigators
-
Adriana R Marques, M.D. · National Institute of Allergy and Infectious Diseases (NIAID)
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-02-28
- Primary Completion
- 2028-06-30
- Completion
- 2028-06-30
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Novel Diagnostics for Early Lyme Disease
NCT03963635 ·Status: UNKNOWN
-
A Comprehensive Clinical, Microbiological and Immunological Assessment of Patients With Suspected Post Treatment Lyme Disease Syndrome and Selected Control Populations
NCT00001539 ·Status: RECRUITING
-
Phase 1/2 Lyme Vaccine Study
NCT01504347 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study to Evaluate the Safety and Immunogenicity of mRNA-1975 and mRNA-1982 Against Lyme Disease in Participants 18 Through 70 Years of Age
NCT05975099 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Direct Diagnosis of Disseminated Lyme Borreliosis.
NCT04719962 ·Status: UNKNOWN ·Phase: NA
-
Next Generation Sequencing Detection of Lyme Disease
NCT03505879 ·Status: COMPLETED
-
Analysis of Lyme Disease Lesions
NCT00132327 ·Status: COMPLETED
-
A Multicenter Study to Evaluate a Borrelia Diagnostic Test in Subjects With Early Stage or Late Stage Lyme Disease
NCT02741609 ·Status: TERMINATED ·Phase: NA
-
A Study to Learn About Different Dosing Schedules of a Lyme Disease Vaccine in Healthy Adults
NCT07226882 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Biomarker Study of Previously Treated Lyme Disease Volunteers in Comparison to Healthy Volunteers
NCT04835792 ·Status: UNKNOWN
-
SWEtick - a Prospective Multicenter Study of Tick-borne Diseases in Sweden
NCT06781008 ·Status: RECRUITING
-
Risk of Exposure and Prevention of Ticks and Tick-borne Diseases Among Foresters in Alsace
NCT06492668 ·Status: RECRUITING
-
Safety Study of a Vaccine to Help Protect Against Lyme Disease in Healthy Children
NCT05634811 ·Status: COMPLETED ·Phase: PHASE3
-
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of the Safety and Efficacy of Ceftriaxone and Doxycycline in the Treatment of Patients With Seropositive Chronic Lyme Disease
NCT00001101 ·Status: COMPLETED ·Phase: PHASE3
-
Borrelia B-cell Diagnostics
NCT06045416 ·Status: RECRUITING
-
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of the Safety and Efficacy of Ceftriaxone and Doxycycline in the Treatment of Patients With Seronegative Chronic Lyme Disease
NCT00000938 ·Status: COMPLETED ·Phase: PHASE3
-
Perceptions,Social Representations and Experience of Lyme Borreliosis and Ticks in Adolescents Likely to be Infected and Their Parents
NCT05678478 ·Status: COMPLETED
-
First Clinical Study of the Safety and Blood Levels of a Human Monoclonal Antibody (2217LS) Against Lyme Disease Bacteria in Healthy People
NCT04863287 ·Status: COMPLETED ·Phase: PHASE1
-
Immunogenicity and Safety Study of a Vaccine Against Lyme Borreliosis, in Healthy Adults Aged 18 to 65 Years. Randomized, Controlled, Observer-blind Phase 2 Study.
NCT03769194 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Clinical, Microbiological and Epidemiological Characteristics of Recurrent Imported Borreliosis Confirmed by the CNR Borrelia
NCT07335965 ·Status: RECRUITING
-
Ceftriaxone for Post-Treatment Lyme Disease
NCT06785402 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Ceftriaxone Pulse Dose for Post-Treatment Lyme Disease
NCT06611111 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Post Exposure Treatment With Doxycycline for the Prevention of Relapsing Fever
NCT00237016 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Detection of Borrelia Bacteria in Early Stage Lyme Borreliosis Using the T2Lyme Panel
NCT03581279 ·Status: TERMINATED ·Phase: NA
-
Safety, Skin and Plasma Concentration of Azithromycin Dermal Formulation
NCT01243008 ·Status: COMPLETED ·Phase: PHASE1/PHASE2